GLPwatch

Injectable hydrogel for sustained protein release by salt-induced association of hyaluronic acid nanogel.

Macromol Biosci · 2012

Last updated 2026-05-28

Researchers developed a gel made from hyaluronic acid that can carry and slowly release protein-based drugs like exendin-4, which is used in GLP-1 medications. In rats, this gel kept drug levels steady in the blood for a full week after a single injection. The gel forms naturally when mixed with salt and does not damage the proteins it carries.

AI summary of the abstract below.

JournalMacromol Biosci, 2012
Citations64
Relative citation ratio2.36
NIH percentile78
Molecules

Abstract

A hyaluronic acid-based anionic nanogel formed by self-assembly of cholesteryl-group-bearing HA is designed for protein delivery. The HA nanogel spontaneously binds various types of proteins without denaturation, such as recombinant human growth hormone, erythropoietin, exendin-4, and lysozyme. The HA nanogel shows unique colloidal properties, in particular that an injectable hydrogel is formed by salt-induced association of the HA nanogel. A pharmacokinetic study in rats shows that an in situ gel formulation, prepared by simply mixing rhGH and HA nanogel in phosphate buffer, maintains plasma rhGH levels within a narrow range over one week. Therefore, HA nanogels offer a simple method for easy formulation of therapeutic proteins and are effective for sustained protein release systems.

Verbatim abstract via PubMed 22606703 ↗